Clinical Trials

A clinical trial is a research study designed to evaluate potential new treatment options by testing the safety and effectiveness of new or modified cancer drugs, new drug doses, unique approaches to surgery or radiation therapy and varied combinations of treatments.

(Follow the link below each trial for more information)

Breast Cancers

Palbociclib Collaborative Adjuvant Study: A Randomized Phase III Trial of Palbociclib with Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive (HR+) / Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Early Breast Cancer (PALLAS)

https://clinicaltrials.gov/ct2/show/NCT02513394

A Randomized, Double-blind, Placebo-controlled Phase 2 Study of Paclitaxel in Combination with Reparixin Compared to Paclitaxel Alone as Front-line Therapy for Metastatic Triple- Negative Breast Cancer (FRIDA)

https://clinicaltrials.gov/ct2/show/NCT02370238

A Randomized Phase III Post-Operative Trial of Platinum Based Chemotherapy Vs. Observation in Patients with Residual Triple-Negative Basal-Like Breast Cancer Following Neo-adjuvant Chemotherapy

https://clinicaltrials.gov/ct2/show/NCT02445391

A Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer

https://www.clinicaltrials.gov/ct2/show/NCT02750826

A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)-  Women of Asian ethnicity only

https://clinicaltrials.gov/ct2/show/NCT01824836